Clinical Trials in Austin

Showing 4161-4180 of 15,205 trials

A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

NCT05075564

The purpose of this first-in-human, open-label, multicenter, non-randomized study is to investigate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary clinical activity of ES002023 in patients with advanced solid tumors that are relapsed or refractory to standard therapies.

Advanced Solid Tumor

Elpiscience Biopharma, Ltd.8 participantsStarted Dec 2021

Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States • Los Angeles, California, United States +4 more locations

COMPLETEDPhase 4< 1 mile

Adalimumab in JIA-associated Uveitis Stopping Trial

NCT03816397

The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or chronic anterior uveitis (CAU).

UveitisJIA

Nisha Acharya87 participantsStarted Mar 2020

Sacramento, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +18 more locations

A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors

Adalimumab in JIA-associated Uveitis Stopping Trial

Find Trials by Condition in Austin

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

STEM-Parkinson's Disease

Chronic Pain Management In Primary Care Using Behavioral Health Consultants

Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)

Phosphatidylethanol and Other Ethanol Consumption Markers

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

A Study of SEA-CD40 Given With Other Drugs in Cancers

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma